Table 3.

Summary scores (baseline) and change scores for primary and secondary outcome variables.

	Quetiapine	Placebo
YBOCS (baseline)	26.4 (SD4.6)	27.7(SD3.9)
YBOCS (change at week 6)	-7.1(SD7.2)	-7.2(SD8.4)
YBOCS % change	-26.9%	-26%
CGI-Severity (baseline)	5.2 (SD0.8)	5.3 (SD0.8)
CGI-Severity (week 6)	4.1 (SD1.4)	4.1(SD1.5)
MADRS (baseline)	10.6 (SD 4.8)	10.71 (SD 9.8)
MADRS (change at week 6)	-2.6 (SD 6.5)	-3 (SD 8.3)
SDS (baseline)	17.9 (SD 5.3)	19.6(SD4.7)
SDS (change at week 6)	-5.3(SD5.6)	-6.1 (SD4.8)
YGTSS (baseline)	24.7 (SD 19.3)	22.6(SD 22.3)
YGTSS (change at week 6)	-4.5(SD 5.1)	-9.4 (SD 14.6)
YGTSS % change	-18.2%	-41.6%